Marina Roussaki, Senior Scientific Project Manager and Sofia Tsatsouli, New Product Development ManagerEstablished in Greece in 2016, the company's commitment to scientific excellence is underscored by collaborations with a diverse network of industrial and academic partners. Over the years, it has successfully expanded its customer base and formed strategic alliances.
A recent $5 million investment from COSMOS Health Inc (NASDAQ: COSM) signifies a milestone in its innovation journey, highlighting Cloudpharm's standing in the industry and emphasising the ultimate objective of providing comprehensive solutions to the pharmaceutical industry and enhancing the quality of life.
Innovative Solutions for Healthcare Advancement
Specialising in the discovery of bioactive compounds, Cloudpharm stands as a trailblazer, empowering pharmaceutical enterprises to embrace a culture of modernisation in drug development.
“Beyond conventional boundaries, we dedicate ourselves to advancing next-generation food supplements, offering pharmaceutical companies an opportunity to meet the growing demand for advanced healthcare solutions,” says Sofia Tsatsouli, new product development manager, Cloudpharm.
Leveraging proprietary technology and AI computational methodologies, Cloudpharm integrates state-of-the-art tools to enhance R&D processes, ensuring swift and precise outcomes for clients.
A key focus lies in drug repurposing, providing pharmaceutical enterprises with the means to explore new therapeutic applications for existing drugs, significantly reducing the time and costs associated with conventional drug development. With expertise ranging from bioactive molecule identification to drug repurposing and the design and development of medical devices and nutraceutical products, Cloudpharm offers comprehensive services to propel the healthcare industry into novel advancements.
In novel hit detection and hit-to-lead optimisation, Cloudpharm employs an advanced collaborative approach, tailoring hit identification strategies to each client's unique targets for a focused and efficient outcome. Emphasising on real time communication, the company conducts regular updates and feedback sessions to align efforts with specific goals, adhering to project timelines and budgets while managing projects efficiently without compromising quality. In navigating uncertainties in drug discovery, Cloudpharm implements proactive risk mitigation, anticipating challenges and developing contingency plans during hit-to-lead optimisation, with a comprehensive strategy that integrates advanced screening techniques, medicinal chemistry expertise and iterative refinement using machine learning.
Innovative Approaches Across Health Sectors
Cloudpharm’s processes delve into the intricacies of pharmaceutical compounds and their potential therapeutic applications. Regarding nutraceuticals and medical devices, Cloudpharm prioritises advancement and impactful collaborations, aiming to bridge the gap between nutrition and health, promoting healthy aging and wellness.
Drug-related projects focus on molecular structures and pharmacological effects. In contrast, initiatives related to nutraceuticals and medical devices encompass a wider array of health interventions, which involve elements of diet and the functionalities of devices.
The ultimate objective is to provide comprehensive solutions to the pharmaceutical industry, ultimately enhancing the quality of life on a global scale
Pioneering Innovation in Healthcare
In an engagement showcasing Cloudpharm's diverse capabilities, the company responded to LIFE NLB's invitation for an innovative food supplement targeting musculoskeletal diseases, leading to the development of a dietary supplement for osteopenia rooted in gut microbiome mechanisms. This initiative not only resulted in a novel formula but also laid the foundation for an ambitious R&D project, OSTEOME.
Under this project, Cloudpharm explored the role of the human gut microbiome in bone remodeling through in vitro studies and clinical interventions. The success of OSTEOME is a testament to Cloudpharm's ability to leverage collaborations and drive impactful R&D projects, demonstrating the positive outcomes achievable through strategic partnerships and innovative approaches in both pharmaceutical and nutraceutical domains.
Cloudpharm stands out in the pharmaceutical industry with its innovative technologies and advanced computational methodologies in R&D, demonstrating a commitment to cutting-edge AI-based approaches. The strategic focus on drug repurposing aligns with industry trends, accelerating development timelines and reducing costs.
